Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: News

LifeArc funds new projects to address and prevent global threat of dengue fever

LifeArc funds new projects to address and prevent global threat of dengue fever
p p Read More

The mosquito-borne viral disease is responsible for an estimated 390 million cases globally

June 13, 2024 dengue fever, India Institute of technology Roorkee, LifeArc, Monash Biomedicine Discovery Institute, News, Tranalab Pvt, viral diseases

New study reveals how brain cell communication is linked to Alzheimer’s disease

New study reveals how brain cell communication is linked to Alzheimer’s disease
p p Read More

Two support cells, microglia and astrocytes, were found to communicate with each other

June 12, 2024 Alzheimer's disease, astrocytes, Francis Crick Institute, microglia, neurodegenerative conditions, News, UCL UK Dementia Research Institute, VIB-KU Leuven Center for Brain and Disease Research

ICL receives £10m donation to advance heart and lung research

ICL receives £10m donation to advance heart and lung research
p p Read More

The donation will help scientists and clinicians collaborate and make new advances in research

June 12, 2024 cardiovascular disease, Dr Victor Phillip Dahdaleh building, Dr Victor Phillip Dahdaleh Graduate Centre for Respiratory and Cardiac Sciences, Imperial College London, National Heart and Lung Institute, News, respiratory disease, Victor Dahdaleh Charitable Foundation

US researchers develop AI liquid biopsy test to help identify lung cancer earlier

US researchers develop AI liquid biopsy test to help identify lung cancer earlier
p p Read More

The leading cause of cancer globally accounts for an estimated 1.8 million deaths annually

June 11, 2024 artificial intelligence, Johns Hopkins Kimmel Cancer Center, lung cancer, News, Oncology

LucyTx announces additional $12.5m research funding for neurological diseases

LucyTx announces additional .5m research funding for neurological diseases
p p Read More

Alzheimer’s and Parkinson’s disease are responsible for more than 30 million cases globally

June 11, 2024 Alzheimer's disease, Bill & Melinda Gates Foundation, Lucy Therapeutics, Michael J. Fox Foundation, neurological conditions, News, Parkinson's disease, Parkinson’s UK, Rett syndrome, Safar Partners

New paediatric blood test to prevent sudden death from hereditary heart condition

New paediatric blood test to prevent sudden death from hereditary heart condition
p p Read More

Hypertrophic cardiomyopathy is a rare condition that affects up to 1,000 children in the UK

June 10, 2024 Action Medical Research, Great Ormond Street Hospital, hypertrophic cardiomyopathy, LifeArc, News, University College London

Dana-Farber Cancer Institute and OncoHost partner for renal cell carcinoma research

Dana-Farber Cancer Institute and OncoHost partner for renal cell carcinoma research
p p Read More

Accounting for 4% of all cases, kidney cancer is currently the sixth most common cancer diagnosed in the […]

June 10, 2024 Dana-Farber Cancer Institute, kidney cancer, News, OncoHost, PROPHETIC, renal cell carcinoma

Serac’s imaging agent marks a breakthrough in endometriosis detection

Serac’s imaging agent marks a breakthrough in endometriosis detection
p p Read More

Early-stage endometriosis now visible through non-invasive imaging

June 7, 2024 data, endometriosis, News, serac

Boehringer Ingelheim’s survodutide shows promise in liver fibrosis treatment

Boehringer Ingelheim’s survodutide shows promise in liver fibrosis treatment
p p Read More

Phase 2 trial reveals significant improvement in MASH patients

June 7, 2024 boehringeringelheim, liver, News, survodutide

Amgen’s trial brings new hope for IgG4-RD patients

Amgen’s trial brings new hope for IgG4-RD patients
p p Read More

Inebilizumab shows sound efficacy in landmark research

June 6, 2024 Amgen, igg4-rd, Inebilizumab, News

Posts navigation

Posts pagination

« Previous 1 … 55 56 57 … 78 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy